Abstract

The high recurrence rate of muscle noninvasive bladder cancer (BC) dictates the search for new methods of surgical treatment. The problem of bladder cancer (BC) treatment is very urgent in urology, because of high morbidity, difficulties in determining the optimal treatment tactics, necessity of long-term follow-up examinations, high recurrence rate and progression. Risk and progression criteria have been developed to identify groups of patients in need of closer follow-up, which can be quantified using risk calculators for recurrence and tumour progression. Although there are clear guidelines for the treatment of patients with bladder cancer, it is also believed that the rate of recurrence depends on the quality of the primary surgical procedure performed [1,2].

Highlights

  • The aim of the study was to evaluate the efficacy and safety of removal of bladder (PB) tumours in a single block compared to standard transurethral resection (TUR).The USA Journals Volume 03 Issue 06-2021

  • Materials and Methods: We studied 101 patients over the 5-year period, 34 of them were in the main group which were operated on using the MBTUR method

  • The comparative analysis of recurrence-free survival and survival to progression of patients with primary NIRMP operated on by the developed MBTUR method was as follows: ─ gender; ─ age; ─ tumour size in the largest dimension; ─ tumour localisation in the bladder;83 ─ Tumour grade (Ta; T1); ─ Tumour histological differentiation (G1; G2; G3); ─ Tumour distribution according to EORTC risk groups

Read more

Summary

Introduction

The aim of the study was to evaluate the efficacy and safety of removal of bladder (PB) tumours in a single block (en bloc) compared to standard transurethral resection (TUR).The USA Journals Volume 03 Issue 06-2021. The aim of the study was to evaluate the efficacy and safety of removal of bladder (PB) tumours in a single block (en bloc) compared to standard transurethral resection (TUR).

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call